Language Selection

YOU ARE USING THE CNPHI QA SYSTEM (LIBERTY)
Français

Molecular detection of Burkholderia mallei/pseudomallei by real-time PCR

<<Return to Laboratory
Accredited by the Standards Council of Canada to Laboratory no. 594 - CAN-P-4E (ISO/IEC 17025)

Requisition Forms

Reference Details

Description:

Molecular detection by real-time PCR of Burkholderia mallei/pseodomallei.

Test Category:
Molecular Detection
Pathogen:
Burkholderia mallei
Illnesses and Diseases:
  • Glanders
Specimen:

Whole blood – minimum 0.5 mL, cerebrospinal fluid (CSF) – minimum 0.5 mL, biopsy tissue, powder Pure bacterial culture – plate or swab; Whole blood – EDTA tube; Tissue or CSF – submit in a sterile collection tube; powder – submit in a sterile 2 mL o-ring microcentrifuge tube

Collection Method:

Whole blood – EDTA tube; Tissue or CSF – submit in a sterile collection tube; powder – submit in a sterile 2 mL o-ring microcentrifuge tube.

Specimen Processing, Storage and Shipping:

Store blood samples refrigerated until shipped for testing. Store tissue samples and CSF frozen until shipped for testing. Store bacterial cultures refrigerated until shipped for testing.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

Patient Criteria:

Suspected Burkholderia pseudomallei/mallei infection

Accompanying Documentation:

Completed Bioforensics Assay Development and Diagnostics requisition including sender name, address and telephone number. Patient name or identifier (referring lab #), date of birth, suspected exposure, test(s) requested, clinical history. Type of specimen and date collected. If possible, include the antibiotics administered and travel history.

Comments:
Methods and Interpretation of Results:

Real-time PCR is performed using in-house differentiating molecular assays which distinguish between Burkholderia pseudomallei and Burkholderia mallei. *Note – if Burkholderia mallei is detected by real-time PCR, no further testing can be completed by BADD. The sample will be forwarded to CFIA for further testing. Confirmatory tests of a sample positive for B. pseudomallei by real-time PCR result include gentamicin sensitivity, nitrate reduction, cellular fatty acid (CFA) analysis, and 16S sequencing. CFA analysis and/or 16S sequencing will be performed on all samples negative for B. pseudomallei by real-time PCR, as long as the sample provides bacterial growth by culture.

Turnaround Time:

4 calendar days for a preliminary result and 14 calendar days for a final result.

Contact:
Phone #: 1-877-212-6108
Fax: (204) 789-2140 / (204) 789-5009
References:
Fact Sheets:
Guidelines:
Related Information: